Pre-Existing Disease and Waiting Periods: The Clause Everyone Skips
Reviewed by CA Nikhil Gupta · Last reviewed 24 June 2026
A waiting period delays specified coverage; it does not excuse incomplete disclosure or guarantee every treatment after the period ends.
For broader context, see the Investing, Loans and Personal Finance Hub.
The safest application is the one that discloses diagnoses, symptoms, tests, medicines and prior advice—even where the proposer thinks the condition is minor.
What the rule means in practice
A pre-existing disease is determined under the applicable regulatory definition and the policy wording. Health-insurance rules cap the maximum waiting period for pre-existing diseases and specified diseases at 36 months under the current framework, but a policy may provide a shorter period. The start date and continuity of coverage matter.
For the connected rule, example or next step, see Pre-Existing Disease: Disclosure, Waiting Period and Claim Risk.
The end of a waiting period does not make every medical expense payable. The treatment must still fall within the policy’s coverage, sum insured, room eligibility, network or reimbursement conditions, exclusions, sub-limits and claim procedures. Portability or migration can preserve earned waiting-period credits subject to regulatory and policy conditions.
Non-disclosure and misrepresentation disputes are fact-sensitive. Do not decide on your own that a symptom, medicine or investigation is “irrelevant”. Answer proposal questions accurately and retain a copy of the completed proposal, tele-underwriting recording or medical reports. An agent’s verbal instruction to omit a condition is dangerous.
Decision table
| Term | Meaning | Document to check |
|---|---|---|
| Pre-existing disease | Condition fitting regulatory and policy definition before commencement | Proposal form and medical history |
| PED waiting period | Time before covered PED treatment becomes eligible | Policy schedule and wording |
| Specified disease waiting | Separate period for listed procedures or conditions | Waiting-period section |
| Portability credit | Continuity credit carried subject to rules | Old policies and portability approval |
| Exclusion or sub-limit | Coverage restriction separate from waiting period | Benefit and exclusion clauses |
For the connected rule, example or next step, see Disease-Specific Waiting Periods: Why New Policies Do Not Cover Everything Immediately.
A customer has been taking thyroid medicine for two years but omits it because the agent says it is common. A later claim dispute can become a disclosure issue, even if the treatment claimed is different. The customer should disclose the condition and ask the insurer to underwrite it transparently.
Action checklist
- Complete the proposal yourself or review every answer before signing.
- Disclose diagnoses, symptoms, medicines, tests, surgery and prior advice.
- Compare PED and specified-disease waiting periods across products.
- Keep every policy in the continuity chain for portability evidence.
- Ask the insurer to explain endorsements, loading or exclusions in writing.
- At claim stage, request the exact clause and medical basis for any denial.
Evidence checklist
- Signed or digitally accepted proposal form
- Medical examination and tele-underwriting records
- Current and previous policy schedules
- Portability or migration acceptance
- Prescriptions and diagnostic reports
- Claim denial and medical-review documents
Common mistakes
- Letting an agent fill health answers without review
- Assuming a common condition need not be disclosed
- Confusing waiting-period completion with unlimited coverage
- Losing prior-policy continuity proof
- Buying only on premium price
Red flags
- Blank proposal form
- Agent promises to “handle” non-disclosure
- Permanent exclusion not highlighted
- Different PED dates in insurer records
- Claim denial without identifying clause or medical link
Escalation route
First request a clause-based explanation and review from the insurer. Correct factual errors in medical or proposal records promptly. Use Bima Bharosa and, where eligibility conditions are met, the Insurance Ombudsman. Complex causation or misrepresentation disputes may require medical and legal opinion.
Frequently Asked Questions
Source and review trail
Use the current official instrument, portal or regulator publication before acting. This panel separates the category authority from page-specific references.
- Primary category
- Consumer & Competition Law
- Official starting point
- consumeraffairs.nic.in
Page source links
- IRDAI — Bima Bharosa grievance portal
- IRDAI — Master Circular on Health Insurance Business
- Council for Insurance Ombudsmen — Complaint procedure
- IRDAI consolidated and Gazette-notified regulations
- IRDAI circulars and master circulars
- IRDAI Health Department and health-insurance regulatory resources
- Master Circular on Health Insurance Business — IRDAI/HLT/CIR/PRO/84/5/2024